DVA vs IMA · P/E 14, rev $12.82B vs rev $9.2M
DaVita HealthCare Partners Inc (DVA) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. IMA currently screens at market cap $64.7M.
Not investment advice. Open the DVA and IMA stock pages for the full models.
Not investment advice.